Walking at Faster Speeds Linked to Reduction in Risk for Type 2 Diabetes
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Nov. 29, 2023 -- Walking at faster speeds seems to be associated with a reduction in the risk for type 2 diabetes, according to a review published online Nov. 28 in the British Journal of Sports Medicine.
Ahmad Jayedi, Ph.D., from the University of Medical Sciences in Semnan, Iran, and colleagues examined the association between walking speed and the risk for type 2 diabetes in a systematic review and meta-analysis of 10 cohort studies.
The researchers found that for average/normal walking (3.2 to 4.8 km/hour), fairly brisk walking (4.8 to 6.4 km/hour), and brisk/striding walking (>6.4 km/hour), compared with easy/casual walking (<3.2 km/hour), the relative risks (95 percent confidence intervals) of type 2 diabetes were 0.85 (0.70 to 1.00), 0.76 (0.65 to 0.87), and 0.61 (0.49 to 0.73). Across subgroups based on adjustment for the total volume of physical activity and time spent walking per day, no significant or credible difference was seen. The risk for type 2 diabetes decreased significantly at a walking speed of 4 km/hour and greater according to a dose-response analysis.
"While current strategies to increase total walking time are beneficial, it may also be reasonable to encourage people to walk at faster speeds to further increase the health benefits of walking," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-11-30 00:33
Read more
- Semaglutide Beneficial for People With Obesity, Knee Osteoarthritis
- Most ERs Not Fully Equipped to Treat Pediatric Patients
- Love Bread & Pasta? Humans' Hunger for Carbs Has Ancient Roots
- Progression-Free Survival Improved With Nivolumab + AVD in Hodgkin Lymphoma
- One in Six Emergency Departments Have High Pediatric Readiness
- Standing More During the Day Does Not Cut Cardiovascular Risk
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions